provider
Search result for "Solr search content"
Search Result for "hematology"
provider
Brittany Altermatt, ANP Adult Nurse Practitioner, Gastrointestinal Oncology
Clinical Trial
A Phase 0, Investigator Initiated Study to Determine the Bioavailability of Sacituzumab Govitecan in Breast Brain Metastasis and Glioblastoma (CTMS# 19-0069)
Single center, non-randomized, Phase 0 study. Sacituzumab Govitecan given preoperatively, followed by craniotomy with surgery or biopsy of brain tumors (GBM and metastatic brain tumors from Breast) and intraoperative tissue collection will follow with contemporaneous CSF (depending on tumor location) and whole blood (serum) sampling.
provider
Neil Newman, MD Radiation Oncology, Thoracic Radiation Oncology
provider
Gary Lewis, MD Radiation Oncology, Gynecologic Oncology
Clinical Trial
S2015 Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (CTMS# 23-0072)
The primary objective of the trial is to assess whether there is no difference in disease-free survival for patients treated with a 1cm excision margin when compared to a 2cm margin for stage II primary melanomas (AJCC 8th edition; pT2b-pT4b).
provider
Edward Medina, M.D. Clinical Pathology, Hematopathology
provider
Natalie Poullard, MS, MA Genetic Counseling, Cancer Genetics & High-Risk Screening
provider